Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tranexamic Acid in Prosthetic Knee Surgery
NCT03386656Phase 3Completed
- Sponsor
- Andalusian Progress and Health Public Foundation
- Start
- Nov 2017
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in osteoarthritis (OA) (2 arms), sponsored by Andalusian Progress and Health Public Foundation. Primary endpoint: Saving blood loss in knee surgery. Started Nov 2017; status: completed.
02
Drugs
tranexamic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03386656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03386656.